Literature DB >> 9858374

D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine has no effect.

P Riekkinen1, S Ikonen, M Riekkinen.   

Abstract

The present study examined the efficacy of single and combined treatments with an anticholinesterase, tetrahydroaminoacridine, nicotine and a glycine-B site partial agonist, D-cycloserine, in alleviating the water maze reversal learning defect induced by a medial septal lesion. D-cycloserine (3 and 10 mg/kg) improved reversal learning. Tetrahydroaminoacridine (1 and 3 mg/kg) and nicotine (0.1 and 0.3 mg/kg) had no effect on reversal learning. A combination of tetrahydroaminoacridine 3 mg/kg or nicotine 0.3 mg/kg and D-cycloserine 10 mg/kg was not more effective than D-cycloserine 10 mg/kg alone in improving reversal learning. This suggests that stimulation of NMDA mechanisms may more effectively improve in medial septal-lesioned rats reversal learning processes than stimulation of cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858374     DOI: 10.1097/00001756-199811160-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats.

Authors:  Marta Portero-Tresserra; Margarita Martí-Nicolovius; Mireia Tarrés-Gatius; Ana Candalija; Gemma Guillazo-Blanch; Anna Vale-Martínez
Journal:  Psychopharmacology (Berl)       Date:  2018-02-28       Impact factor: 4.530

2.  D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.

Authors:  Edward D Levin; Susan Slade; Corinne Wells; Ann Petro; Jed E Rose
Journal:  Pharmacol Biochem Behav       Date:  2010-12-28       Impact factor: 3.533

3.  NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice.

Authors:  Armin Zlomuzica; Maria A De Souza Silva; Joseph P Huston; Ekrem Dere
Journal:  Psychopharmacology (Berl)       Date:  2007-05-12       Impact factor: 4.415

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.